Betge, J., Chi-Kern, J., Schulte, N., Belle, S., Gutting, T., Burgermeister, E., . . . Härtel, N. (2018). A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). BMC cancer, 18, . https://doi.org/10.1186/s12885-018-4665-2
Chicago-Zitierstil (17. Ausg.)Betge, Johannes, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Matthias Ebert, und Nicolai Härtel. "A Multicenter Phase 4 Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/− Nab-paclitaxel in Elderly Pancreatic Cancer Patients (GrantPax)." BMC Cancer 18 (2018). https://doi.org/10.1186/s12885-018-4665-2.
MLA-Zitierstil (9. Ausg.)Betge, Johannes, et al. "A Multicenter Phase 4 Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/− Nab-paclitaxel in Elderly Pancreatic Cancer Patients (GrantPax)." BMC Cancer, vol. 18, 2018, https://doi.org/10.1186/s12885-018-4665-2.